Not recruiting
Neovascular age-related macular degeneration
Not recruitingA study comparing 4D-150 and aflibercept for adults with abnormal blood vessel growth in the eye due to age-related macular degeneration
Registered drugNo placebo
A study comparing 4D-150 and aflibercept for adults with abnormal blood vessel growth in the eye due to age-related macular degeneration
Registered drugNo placebo
- Disease:Neovascular age-related macular degeneration
- Substances:AfliberceptDifluprednate+1
Countries:
Bulgaria
Bulgaria- Participants:18–64 years · 65+ years
- Substances:Aflibercept



